ArticleNature medicine2022

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants.

Nicole L Welch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.